Thyroid cancer rates are up worldwide. Total thyroidectomy rates are declining. This apparent dichotomy is driven by two trends: increased diagnosis of thyroid cancer, largely due to increased availability and utilization of advanced imaging, and technological advances that enable physicians to treat thyroid cancers and nodules more precisely.
Resectable stage IVA/IVB tumors should be treated with surgery followed by chemoradiation, with consideration for dabrafenib/trametinib biotherapy for BRAFV600E-mutated tumors.
Novel sternocleidomastoid flap augmentation of tracheal reconstructive technique for invasive thyroid cancer is designed to incorporate the sternocleido-mastoid muscle flap directly over the tracheal suture line to minimize the risk of anastomotic complications.
Among the highlighted findings in this analysis is the importance of laryngoscopic examination to detect preoperative vocal cord paralysis.
Despite the increased morbidity and risks associated with revision surgery, select patients benefit from re-operation in the setting of recurrent well-differentiated thyroid cancer.
The literature supports the use of thyroglobylin washout as an adjunct to fine-needle aspiration cytology (FNAC) as it improves diagnostic accuracy.
Medullary thyroid carcinoma is a relatively rare thyroid cancer accounting for about 5% to 10% of all thyroid cancers.
Increased rates of thyroid cancer among World Trade Center (WTC)-exposed firefighters and emergency medical service personnel who participated in rescue/recovery efforts after 9/11 are likely due to medical surveillance rather […]
Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.
An expert panel reviewed the main changes to thryoid cancer management from molecular testing to surveillance in select cases, and from nerve monitoring to the choice between total thyroidectomy over hemi-thyroidectomy for certain tumors.